*<p>VL = HIV RNA Viral load; NNRTI - non-nucleoside reverse transcriptase inhibitor;</p
<p>AZT: Zidovudine; d4T: Stavudine; TDF: Tenofovir; IQR: Interquartile Range; NNRTI: non-nucleoside ...
<p>Demographic, clinical, virologic, and immunological characteristics of study participants at the ...
<p>95% confidence intervals are in parenthesis.</p>a<p>Men who had sex with men <i>versus</i> other ...
<p>PIs: protease inhibitors; NRTIs: nucleoside reverse transcriptase inhibitors; NNRTIs: non-nucleos...
<p>Clinical and demographic characteristics of the study subjects by the viral load level (n = 636)....
<p><u>Footnote:</u> n, number; IQR, interquartile range; NRTI, nucleoside reverse transcriptase inhi...
<p>Abbreviations: T0, time of first viral load result using the ultrasensitive Taqman assay (study e...
<p>ART: antiretroviral therapy, NRTI: nucleoside reverse transcriptase inhibitors, NNRTI: non-nucleo...
<p>Groups of participants with genital viral load (GVL) < 40 HIV RNA copies/mL (N = 132) versus GVL≥...
<p>IQR: interquartil range; ART: antiviral therapy; PI: protease inhibitor; NRTI: nucleoside reverse...
Demographic characteristics of the study population stratified by index cases, HIV uninfected partne...
<p>M: median. N(t)RTIs: nucleos(t)ide analogue reverse transcriptase inhibitors. NNRTI: nonnucleosid...
<p>Values are median <i>(interquartile range)</i>.</p><p>ART: Highly active antiretroviral therapy; ...
<p>BMI: Body mass index; SD: Standard deviation; NNRTI: Non-nucleoside reverse transcriptase inhibit...
<p>Data is presented as mean ± SEM or n (%), ART = Antiretroviral Therapy; TDF = Tenofovir Disoproxi...
<p>AZT: Zidovudine; d4T: Stavudine; TDF: Tenofovir; IQR: Interquartile Range; NNRTI: non-nucleoside ...
<p>Demographic, clinical, virologic, and immunological characteristics of study participants at the ...
<p>95% confidence intervals are in parenthesis.</p>a<p>Men who had sex with men <i>versus</i> other ...
<p>PIs: protease inhibitors; NRTIs: nucleoside reverse transcriptase inhibitors; NNRTIs: non-nucleos...
<p>Clinical and demographic characteristics of the study subjects by the viral load level (n = 636)....
<p><u>Footnote:</u> n, number; IQR, interquartile range; NRTI, nucleoside reverse transcriptase inhi...
<p>Abbreviations: T0, time of first viral load result using the ultrasensitive Taqman assay (study e...
<p>ART: antiretroviral therapy, NRTI: nucleoside reverse transcriptase inhibitors, NNRTI: non-nucleo...
<p>Groups of participants with genital viral load (GVL) < 40 HIV RNA copies/mL (N = 132) versus GVL≥...
<p>IQR: interquartil range; ART: antiviral therapy; PI: protease inhibitor; NRTI: nucleoside reverse...
Demographic characteristics of the study population stratified by index cases, HIV uninfected partne...
<p>M: median. N(t)RTIs: nucleos(t)ide analogue reverse transcriptase inhibitors. NNRTI: nonnucleosid...
<p>Values are median <i>(interquartile range)</i>.</p><p>ART: Highly active antiretroviral therapy; ...
<p>BMI: Body mass index; SD: Standard deviation; NNRTI: Non-nucleoside reverse transcriptase inhibit...
<p>Data is presented as mean ± SEM or n (%), ART = Antiretroviral Therapy; TDF = Tenofovir Disoproxi...
<p>AZT: Zidovudine; d4T: Stavudine; TDF: Tenofovir; IQR: Interquartile Range; NNRTI: non-nucleoside ...
<p>Demographic, clinical, virologic, and immunological characteristics of study participants at the ...
<p>95% confidence intervals are in parenthesis.</p>a<p>Men who had sex with men <i>versus</i> other ...
DOI
Add to ORKG